Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole

Drug Development and Industrial Pharmacy

Volumn 31, Issue 4-5, 2005, Pages 375-383

  Ning, Meiying ^a,b   Guo, Yingzhi ^b   Pan, Huaizhong ^b   Chen, Xianli ^b   Gu, Zhongwei ^b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

Author keywords

Clotrimazole; Liposomes; Niosomes; Vaginal drug delivery

Indexed keywords

ANTIFUNGAL AGENT; CARBOMER; CLOTRIMAZOLE; IMIDAZOLE DERIVATIVE; LIPOSOME; NIOSOME; SORBITAN ESTER; SPAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG SYNTHESIS; DRUG TOLERABILITY; EVALUATION; GEL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; RAT; UROGENITAL SYSTEM;

ADMINISTRATION, INTRAVAGINAL; ANIMALS; ANTIFUNGAL AGENTS; CANDIDIASIS; CLOTRIMAZOLE; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; DRUG STORAGE; FEMALE; GELS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MICROBIAL SENSITIVITY TESTS; PARTICLE SIZE; POLYVINYLS; RATS; RATS, SPRAGUE-DAWLEY; VAGINA;

EID: 24744462679     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1081/DDC-54315     Document Type: Article

References (18)

1. Ceschel, G. C., Maffei, P., & Lombardi, B. S. (2001). Development of a mucoadhesive dosage form for vaginal administration. Drug Development and Industrial Pharmacy, 27, 541-547.
2. Fang, J. Y., Hong, C. T., Chiu, W. T., & Wang, Y. Y. (2001). Effect of liposomes and niosomes on skin permeation of enoxacin. International Journal of Pharmaceutics, 219, 61-72.
3. Farshi, F. S., Ozen, A. Y., & Ercan, M. T. (1996). In vitro studies in the treatment of oral ulcers with liposomal dexamethasone phosphate. Journal of Microencapsulation, 13, 537-544.
4. Ferrer, J. (2000). Vaginal candidosis: epidemiological and etiological factors. International Journal of Cynecology & Obstetrics, 71, S21-S27.
5. Kim, M. K., Chung, S. J., Lee, M. H., Cho, A. R., & Shim, C. K. (1997). Targeted and sustained delivery of hydrocortisone to normal and stratum corneum-removed skin without enhanced skin absorption using a liposome gel. Journal of Controlled Release, 46, 243-251.
6. Lanchares, J. L., & Hernandez, M. L. (2000). Recurrent vaginal candidiasis changes in etiopathogenical patterns. International Journal of Gynecology & Obstetrics, 71, S29-S35.
7. Manconi, M., Sinico, C., Valenti, D., Loy, G., & Fadda, A. M. (2001). Niosomes as carriers for tretinoin. I. Preparation and properties. International Journal of Pharmaceutics, 234, 237-248.
8. Owen, D. H., & Katz, D. F. (1999). A vaginal fluid stimulant. Contraception, 59, 91-95.
9. Pavelié, Ž., Škalko, N., & Jalšenjak, I. (1999). Liposomes contaning drugs for treatment of vaginal infections. European Journal of Pharmaceutical Sciences, 8, 345-351.
10. Pavelié, Ž., Škalko, N., & Jalšenjak, I. (2001). Liposomal gels for vaginal Drug Deliveryery. International Journal of Pharmaceutics, 219, 139-149.
11. Perini, G., Saettone, M. F., Carafa, M., Santucci, E., & Alhaique, F. (1996). Niosomes as carriers for ophthalmic drugs: in vitro/vivo evaluation. Bulletin of Chemicals and Pharmaceutical, 135, 145-146.
12. Schmid, M. H., & Korting, H. C. (1994). Liposomes: a drug carrier system for topical treatment in dermatology. Critical Reviews in Therapeutic Drug Carrier Systems, 11, 97-118.
13. Shahiwala, A., & Misra, A. (2002). Studies in topical application of niosomally entrapped nimesulide. Journal of Pharmacy & Pharmaceutical Sciences, 5(3), 220-225.
14. Uchegbu, I. F., Double, J. A., Turton, J. A., & Florence, A. T. (1995). Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (span-60) niosomes in the mouse. Pharmaceutical Research, 12, 1019-1024.
15. Valenta, C., Wanka, M., & Heidlas, J. (2000). Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug. Journal of Controlled Release, 63, 165-173.
16. Varshosaz, J., Pardakhty, A., Hajhashemi, V. I., & Najafabaci, A. R. (2003). Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Delivery, 10, 251-262.
17. Vora, B., Khopade, A. J., & Jain, N. K. (1998). Proniosome based transdermal delivery of levonorgestrel for effective contraception. Journal of Controlled Release, 54, 149-165.
18. Yoshika, T., Sternberg, B., & Florence, A. T. (1994). Preparation and properties of vesicles (niosomes) of sorbitan monoesters (span 20, span 40, span 60 and span 80) and a sorbitan trimester (span 85). International Journal of Pharmaceutics, 105, 1-6.